Gilead's (GILD) Earnings Miss Estimates in Q3, Sales Beat
Gilead Sciences, Inc. GILD reported mixed results for the third quarter of 2019 as earnings missed expectations while sales managed to marginally surpass the same.
The company delivered earnings of $1.75 per share in the third quarter, declining from $1.84 in the year-ago quarter and missing the Zacks Consensus Estimate by a penny.
Total revenues of $5.60 billion beat the Zacks Consensus Estimate by 0.1% and were roughly flat year over year.
...
https://finance.yahoo.com/news/gileads-g...02613.html
Gilead Sciences, Inc. GILD reported mixed results for the third quarter of 2019 as earnings missed expectations while sales managed to marginally surpass the same.
The company delivered earnings of $1.75 per share in the third quarter, declining from $1.84 in the year-ago quarter and missing the Zacks Consensus Estimate by a penny.
Total revenues of $5.60 billion beat the Zacks Consensus Estimate by 0.1% and were roughly flat year over year.
...
https://finance.yahoo.com/news/gileads-g...02613.html
__________________